An internationally recognized expert and clinician, Dr. Elaine Abrams has over 30 years of experience in comprehensive care and treatment for HIV-infected pregnant women, children and their families. As the senior director for research at ICAP, Abrams leads ICAP’s large research agenda and is responsible for development and implementation of technical assistance, drug access, pediatric and perinatal prevention initiatives for ICAP programs in sub-Saharan Africa and Asia. Abrams was the director of the MTCT-Plus Initiative, the first multi-country family-focused HIV treatment program that demonstrated successful provision of HIV care and antiretroviral treatment for pregnant women and their families in resource-limited settings. Abrams built on this work by ensuring that ICAP’s global portfolio and projects in over 20 countries were informed by and integrated the latest scientific breakthroughs in HIV in a way that was tailored to the specific needs and context of each country. Abrams currently serves as the co-chair of the guidelines group for WHO – Consolidated Guidelines for the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection – and has been actively involved in the development of international, national, and local guidelines and policies for HIV care and treatment. Abrams’ research interests have focused on maternal health, mother-to-child HIV transmission, the natural history of pediatric HIV, and optimizing antiretroviral therapy for infants, children, adolescents, and pregnant and breastfeeding women. Abrams is a professor of epidemiology and pediatrics at Columbia University and holds a medical degree from Columbia University’s College of Physicians and Surgeons.